Back

Prognostic role of inflammatory status in type 2 myocardial infarction

2 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Predictors of outcome in acute coronary syndromes Inflammation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Leonardo Luca Bavuso

S. Orsola-Malpighi Policlinic, Bologna (Italy)

6 More presentations in this session

Presentation thumbnail
Secreted GRP78 attenuates endothelial inflammation and predicts outcome in coronary artery disease
Miss E. Repges (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Hs-CRP modifies the impact of stress hyperglycemia ratio on long-term outcomes in patients with acute coronary syndrome
Miss K. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Ankle brachial index,a non invasive tool predicts cardiovascular events after acute myocardial infarction:a 3 year follow -up study
Mr A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of plasma molecular lipid species in coronary artery disease patients: A prospective cohort study
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
The relationship between daily blood glucose fluctuation and readmission in patients with acute coronary syndrome
Ms X. Wang (Xi'an, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Predictors of outcome in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Biomarker-based risk scores for predicting mortality and major cardiovascular events in patients with myocardial infarction
thumbnail
Congress Presentation
Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources